Sick day management in children and adolescents with diabetes

Affiliations

¹ Pediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle, New South Wales, Australia.
² Department of Pediatrics, NU Hospital Group, Uddevalla Hospital, Uddevalla, and Sahlgrenska Academy, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.
³ Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria.
⁴ School of Nursing, Midwifery and Paramedicine, University of the Sunshine Coast, Petrie, Queensland, Australia.
⁵ Department of Paediatrics, Oak Valley Health, Markham, Ontario, Canada.
⁶ Dr. Warren Lee's Paediatrics, Growth & Diabetes Centre, and KK Hospital, Singapore, Singapore.
⁷ University Hospitals Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, Ohio, USA.
⁸ Institute of Maternal and Child Research (IDIMI), School of Medicine, University of Chile, Santiago, Chile.

Review

Helen Phelan et al. Pediatr Diabetes. 2022 Nov.

. 2022 Nov;23(7):912-925.

doi: 10.1111/pedi.13415.

¹ Pediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle, New South Wales, Australia.
² Department of Pediatrics, NU Hospital Group, Uddevalla Hospital, Uddevalla, and Sahlgrenska Academy, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.
³ Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria.
⁴ School of Nursing, Midwifery and Paramedicine, University of the Sunshine Coast, Petrie, Queensland, Australia.
⁵ Department of Paediatrics, Oak Valley Health, Markham, Ontario, Canada.
⁶ Dr. Warren Lee's Paediatrics, Growth & Diabetes Centre, and KK Hospital, Singapore, Singapore.
⁷ University Hospitals Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, Ohio, USA.
⁸ Institute of Maternal and Child Research (IDIMI), School of Medicine, University of Chile, Santiago, Chile.

No abstract available

Keywords: DKA; ketones; pediatrics; sick day management; type 1 diabetes.

References

1. Muller LM, Gorter KJ, Hak E, et al. Increased risk of infection in patients with diabetes mellitus type 1 or 2. Clin Infect Dis. 2006;150(10):549-553.
1. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23(1):9-15. doi:10.2337/diab.23.1.9
1. Liberatore RR Jr, Barbosa SF, Alkimin M, et al. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2005;6(4):206-212. doi:10.1111/j.1399-543X.2005.00136.x
1. Walker M, Marshall SM, Alberti KG. Clinical aspects of diabetic ketoacidosis. Diabetes Metab Rev. 1989;5(8):651-663. doi:10.1002/dmr.5610050803
1. Lee HJ, Sajan A, Tomer Y. Hyperglycemic emergencies associated with COVID-19 vaccination: a case series and discussion. J Endocr Soc. 2021;5(11):bvab141. doi:10.1210/jendso/bvab141